Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Second Quarter of 2005

Published by: Decision Resources

Published: Oct. 5, 2005 - 21 Pages

The price of this publication has been reduced due to age. The full price was $1,900.

Table of Contents


Overview

United States

European Union

France

Germany

Italy

Spain

United Kingdom

Japan

Outlook and Implications for the Pharmaceutical Industry




Table 1. Average Percentage Increases in Wholesale Acquisition Costs for 195 Drugs Most Frequently Prescribed to US Seniors, 2000-20004

Table 2. Average Increases in Wholesale Acquisition Costs of Widely Prescribed Drug Classes, 2004

Table 3. Contribution of Wholesale Acquisition Cost Changes to Increases in the Average Annual Cost of Therapy for 189 Chronic Therapies Frequently Prescribed to US Seniors, 2000-2004

Table 4. Widely Prescribed Drugs Expected to Lose Patent Protection in France, 2005-2007

Table 5. Proposed Tax Rates on Sales of Prescription Drugs to the Spanish National Health System

Table 6. Average prices of Innovative Medicines in 15 European Countries as a Percentage of Average Spanish Prices




Figure 1. Projected 2005 Drug Spending and Out-of-Pocket Payments for Medicare Beneficiaries in Differing Circumstances

Figure 2. Consumer Price Inflation for Prescription Drugs and Other Medical Costs, 2004

Figure 3. Average Pharmaceutical Price Changes in Germany, January 2003 to April 2005 and January 2005 to April 2005

Figure 4. Monthly Pharmaceutical Expenditures of Germany’s Statutory Health Insurance System, January 2003-June 2005

Abstract

In this report, we review major developments in the second quarter of 2005 in the pharmaceutical pricing, reimbursement, and prescribing environment in the major pharmaceutical markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan), including the ongoing preparations for implementation of the Medicare drug benefit plan in the United States and a new European Union strategy for the pharmaceutical industry that would, among other objectives, lead to a relaxation of pricing controls, faster market access for new drugs, and harmonization of standards for health technology assessment. We focus on measures that health care payers are using to curb their drug expenditures and improve patient access to medications. We conclude with an assessment of the outlook and implications for the pharmaceutical industry.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009